ClinicalCodes.org

An online clinical codes repository to improve validity and reproducibility of medical database research

Research article:

Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database

Reference:

Caroline Fairhurst, Ian Watt, Fabiola Martin, Martin Bland, and William J. Brackenbury(2014) Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database. BMJ Open, doi:

Link to fulltext article
Abstract
Introduction: Metastasis from solid tumours is associated with significant morbidity and mortality, and is the leading cause of cancer-related deaths. Voltage-gated sodium channels (VGSCs) are drug targets for the treatment of epilepsy. VGSCs are also present in cancer cells, where they regulate metastatic cell behaviours, including cellular movement and invasion. Treating cancer cells with the VGSC-inhibiting anticonvulsant phenytoin reduces cellular invasion and migration. Together, these suggest that VGSCs may be useful targets for inhibiting metastasis. The purpose of this study is to test the hypothesis that use of VGSC-inhibiting drugs will reduce metastasis, and therefore increase survival time in cancer patients. Methods and analysis: A cohort study based on primary care data from the QResearch database will include patients with one of three common tumours: breast, bowel, and prostate. The primary outcome will be overall survival from date of cancer diagnosis. Cox proportional hazards regression will be used to compare the survival of cancer patients taking VGSC-inhibiting drugs (including anticonvulsants and Class I antiarrhythmic agents) with cancer patients not exposed to these drugs, adjusting for age and sex. Exposure to VGSC-inhibiting drugs will be defined as having at least one prescription for these drugs prior to cancer diagnosis. High and low exposure groups will be identified based on length of use. A number of sensitivity and secondary analyses will be conducted. Ethics and dissemination: The protocol has been independently peer-reviewed and approved by the QResearch Scientific Board. The project has also been approved by the University of York Ethical Review Process. The results will be presented at international conferences and published in an open access peer-reviewed journal, in accordance with the STROBE criteria.
Author for correspondence
William J. Brackenbury
Email for correspondence
william.brackenbury@york.ac.uk

Code list: res17: Colorectal cancer

60 codes in list

Code Coding system Description Entity type List name
B13 Read Malignant neoplasm of colon diagnostic res17: Colorectal cancer
B130 Read Malignant neoplasm of hepatic flexure of colon diagnostic res17: Colorectal cancer
B130-99 Read Ca hepatic flexure - colon diagnostic res17: Colorectal cancer
B131 Read Malignant neoplasm of transverse colon diagnostic res17: Colorectal cancer
B131-99 Read Ca transverse colon diagnostic res17: Colorectal cancer
B132 Read Malignant neoplasm of descending colon diagnostic res17: Colorectal cancer
B132-99 Read Ca descending colon diagnostic res17: Colorectal cancer
B133 Read Malignant neoplasm of sigmoid colon diagnostic res17: Colorectal cancer
B133-99 Read Ca sigmoid colon diagnostic res17: Colorectal cancer
B134 Read Malignant neoplasm of caecum diagnostic res17: Colorectal cancer
B134-1 Read Carcinoma of caecum diagnostic res17: Colorectal cancer
B135 Read Malignant neoplasm of appendix diagnostic res17: Colorectal cancer
B136 Read Malignant neoplasm of ascending colon diagnostic res17: Colorectal cancer
B136-99 Read Ca ascending colon diagnostic res17: Colorectal cancer
B137 Read Malignant neoplasm of splenic flexure of colon diagnostic res17: Colorectal cancer
B137-99 Read Ca splenic flexure - colon diagnostic res17: Colorectal cancer
B138 Read Malignant neoplasm, overlapping lesion of colon diagnostic res17: Colorectal cancer
B139 Read Hereditary nonpolyposis colon cancer diagnostic res17: Colorectal cancer
B13y Read Malignant neoplasm of other specified sites of colon diagnostic res17: Colorectal cancer
B13z Read Malignant neoplasm of colon NOS diagnostic res17: Colorectal cancer
B13z-1 Read Colonic cancer diagnostic res17: Colorectal cancer
B14 Read Malignant neoplasm of rectum, rectosigmoid junction and anus diagnostic res17: Colorectal cancer
B140 Read Malignant neoplasm of rectosigmoid junction diagnostic res17: Colorectal cancer
B140-99 Read Ca rectosigmoid junction diagnostic res17: Colorectal cancer
B141 Read Malignant neoplasm of rectum diagnostic res17: Colorectal cancer
B141-1 Read Carcinoma of rectum diagnostic res17: Colorectal cancer
B141-2 Read Rectal carcinoma diagnostic res17: Colorectal cancer
B141-99 Read Adenocarcinoma of rectum diagnostic res17: Colorectal cancer
B1420 Read Malignant neoplasm of cloacogenic zone diagnostic res17: Colorectal cancer
B143 Read Malignant neoplasm of anus unspecified diagnostic res17: Colorectal cancer
B14-99 Read Ca rectum + Ca anus diagnostic res17: Colorectal cancer
B14y Read Malig neop other site rectum, rectosigmoid junction and anus diagnostic res17: Colorectal cancer
B14z Read Malignant neoplasm rectum,rectosigmoid junction and anus NOS diagnostic res17: Colorectal cancer
B14z-99 Read Ca rectum + Ca anus NOS diagnostic res17: Colorectal cancer
B1z0-1 Read Cancer of bowel diagnostic res17: Colorectal cancer
B575 Read Secondary malignant neoplasm of large intestine and rectum diagnostic res17: Colorectal cancer
B5750 Read Secondary malignant neoplasm of colon diagnostic res17: Colorectal cancer
B5751 Read Secondary malignant neoplasm of rectum diagnostic res17: Colorectal cancer
B575z Read Secondary malig neop of large intestine or rectum NOS diagnostic res17: Colorectal cancer
B803 Read Carcinoma in situ of colon diagnostic res17: Colorectal cancer
B8030 Read Carcinoma in situ of hepatic flexure of colon diagnostic res17: Colorectal cancer
B8031 Read Carcinoma in situ of transverse colon diagnostic res17: Colorectal cancer
B8032 Read Carcinoma in situ of descending colon diagnostic res17: Colorectal cancer
B8033 Read Carcinoma in situ of sigmoid colon diagnostic res17: Colorectal cancer
B8036 Read Carcinoma in situ of ascending colon diagnostic res17: Colorectal cancer
B8037 Read Carcinoma in situ of splenic flexure of colon diagnostic res17: Colorectal cancer
B8038 Read High grade dysplasia of colon diagnostic res17: Colorectal cancer
B803z Read Carcinoma in situ of colon NOS diagnostic res17: Colorectal cancer
B804 Read Carcinoma in situ of rectum and rectosigmoid junction diagnostic res17: Colorectal cancer
B8040 Read Carcinoma in situ of rectosigmoid junction diagnostic res17: Colorectal cancer
B8041 Read Carcinoma in situ of rectum diagnostic res17: Colorectal cancer
B804z Read Carcinoma in situ of rectum or rectosigmoid junction NOS diagnostic res17: Colorectal cancer
B902 Read Neop of uncertain behaviour stomach, intestines and rectum diagnostic res17: Colorectal cancer
B9024 Read Neoplasm of uncertain behaviour of colon diagnostic res17: Colorectal cancer
B9025 Read Neoplasm of uncertain behaviour of rectum diagnostic res17: Colorectal cancer
B902z Read Neop of uncertain behaviour stomach, intestine or rectum NOS diagnostic res17: Colorectal cancer
BB5N Read [M]Adenomatous and adenocarcinomatous polyps of colon diagnostic res17: Colorectal cancer
EGTON2B152 Read Cause of Death- Ca Rectum diagnostic res17: Colorectal cancer
EMISNQHE41 Read Hereditary nonpolyposis colon cancer diagnostic res17: Colorectal cancer
HNG0201 Read [RFC] Cancer of the rectum diagnostic res17: Colorectal cancer

0 comments have been posted.

Please log in to leave a comment.